News

5 posts

News

PREDICTION ADR partners find new gene for ACE inhibitor-induced cough in collaboration with US eMERGE network.

Around 10% of individuals taking ACE inhibitors (ACEI) to control blood pressure will develop a persistent dry cough. This leads to inappropriate antiobiotic use and eventually to discontinuation of the ACEI medication. US investigators in collaboration with PREDICTION ADR have found a common gene variant that identifies individuals more susceptible […]

ASPER Biotech markets genetic test for statin ADR

PREDICTION-ADR partner Asper Biotech is working on the implementation of new reliable and validated testing panels to predict the side effects of statins and ACE inhibitors. Asper’s new testing portfolio – Asper Cardiogenetics – launched in 2015 – offers among other options risk assessment for developing adverse drug reactions, namely statin-induced myopathy. Currently the validated test […]

Second newsletter published

The second newsletter of the PREDICTION-ADR consortium has been published. Read about the recent annual plenary meeting of the consortium held in Uppsala where the progress of the research was discussed. PREDICTION-ADR partner ASPER Biotech is now marketing a genetic test which can help predict which patients are likely to suffer […]

First Newsletter Published

The first newsletter of the PREDICTION-ADR consortium has been published. Read about the recent annual plenary meeting of the consortium held in Utrecht where the recent progress of the research was discussed. The PREDICTION-ADR team have also been active in defining the specific phenotypes of statin associated myopathy and ACE […]